GYRE Gyre Therapeutics, Inc. - Common Stock
$7,21
Fiyat · Ağu 19, 2026
Temel veriler itibarıyla Ağu 7, 2026
52 Haftlık Aralık
$5–$9
44% of range
Analist Derecelendirmesi
BUY
9 analysts
Fiyat Hedefi
$19
+159% upside
P/E (TTM)
360.2
ROE
11.7%
Net Kâr Marjı
8.5%
GYRE Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$7.21
Piyasa Değeri
$658M
P/E (TTM)
360.2
EPS (TTM)
$0.02
Gelir (TTM)
$117M
Temettü Verimi
—
ROE
11.7%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$5 – $9
GYRE Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$117M
2017-12-31
→
2025-12-31
Hisse Başına Kâr
$0.02
2021-12-31
→
2025-12-31
Serbest Nakit Akışı
$-180.0K
2016-12-31
→
2025-12-31
Marjlar
8.5%
2023-12-31
→
2024-12-31
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
GYRE
Akran Ortalaması
P/E (TTM)
360.2
19.6
P/S (TTM) (F/S (TTM))
5.6
6.4
P/B (F/D)
6.2
2.6
Price / FCF (Fiyat / Serbest Nakit Akışı)
-3655.1
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
GYRE
Akran Ortalaması
Operating Margin (Faaliyet Kâr Marjı)
9.8%
—
Net Profit Margin (Net Kâr Marjı)
8.5%
-104.2%
ROA
6.8%
-40.3%
ROE
11.7%
-42.4%
ROIC
7.4%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
GYRE
Akran Ortalaması
Current Ratio (Cari Oran)
5.6
5.4
Quick Ratio (Cari Oran)
4.6
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
GYRE
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
10.2%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
4.5%
—
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)
41.0%
—
EPS YoY (EPS YB)
-60.0%
—
Net Income YoY (Net Gelir Yıllık Bazda)
-44.8%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
GYRE
Akran Ortalaması
Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR
Temettü Verimi
—
Temettü Ödeme Oranı
—
5 Yıllık Temettü CAGR
—
| Ex-tarihi | Miktar |
|---|---|
| 13 Ocak 2023 | $3,6000 |
| 21 Eylül 2022 | $21,4500 |
| 20 Ağustos 2015 | $896,1750 |
GYRE Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
9 analist
- Güçlü Al 3 33,3%
- Al 5 55,6%
- Tut 1 11,1%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
3 analist · 2026-08-14
Medyan
$18.00
Ortalama
$18.67
← Tüm hedeflerin altında
$7.21
Düşük
$18.00
Yüksek
$20.00
Medyan hedef
$18.00
+149,8%
Ortalama hedef
$18.67
+159,1%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
0.01%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 30 Haziran 2026 | $-0.12 | $-0.09 | -0.03% |
| 31 Mart 2026 | $-0.04 | $-0.07 | 0.03% |
| 31 Aralık 2025 | $0.05 | $0.06 | -0.01% |
| 30 Eylül 2025 | $0.08 | $0.03 | 0.05% |
| 30 Haziran 2025 | $0.02 | $0.03 | -0.01% |
| 31 Mart 2025 | $0.03 | $0.03 | -0.00% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| GYRE | $645M | 353.0 | 10.2% | 8.5% | 11.7% | — |
| CTMX | $725M | — | -44.8% | -22.8% | -15.9% | — |
| RGNX | $733M | -3.8 | 104.5% | -113.8% | -122.5% | — |
| BBOT | $1.00B | -2.9 | — | — | -146.2% | — |
| NGNE | $319M | -4.9 | — | — | -33.6% | — |
| STTK | $231M | -5.2 | -82.5% | -4880.9% | -70.0% | — |
| NVCT | $194M | -5.7 | — | — | -149.9% | — |
| ALLO | $314M | -1.6 | -76.8% | — | -59.9% | — |
| IRWD | $550M | 22.5 | -15.7% | 8.1% | -8.5% | — |
| TECX | $391M | -5.2 | — | — | -27.7% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 17
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $117M | $106M | $113M | $102M | $7M | $21M | · | $6.0K | $1M | · | · | $275.0K | |
| Cost of Revenue | $5M | $4M | $5M | $5M | · | · | · | · | · | · | · | · | |
| Gross Profit | · | $102M | $109M | $97M | · | · | · | · | · | · | · | · | |
| R&D Expense | $14M | $12M | $14M | · | $69M | $53M | $44M | $21M | $13M | $12M | $6M | $5M | |
| SG&A Expense | $21M | $16M | $15M | $17M | $19M | $16M | $13M | $12M | $10M | $9M | $10M | $4M | |
| Operating Expenses | $105M | $90M | $176M | $88M | $95M | $78M | $57M | $34M | $23M | $21M | $16M | $9M | |
| Operating Income | $11M | $16M | $-67M | $9M | $-88M | $-57M | $-57M | $-34M | $-22M | $-20M | $-14M | $-8M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | $1M | $23.0K | |
| Other Non-op | $-2M | $-2M | $-2M | · | $-78.0K | $-91.0K | $-39.0K | $2M | $-1.0K | $86.0K | $131.0K | $575.0K | |
| Pretax Income | $14M | $23M | $-77M | $9M | $-88M | · | · | · | · | · | · | $-29M | |
| Income Tax | $5M | $5M | $9M | $5M | · | · | · | · | · | · | · | $3M | |
| Net Income | $10M | $18M | $-85M | $4M | $-88M | $-56M | $-55M | $-30M | $-22M | $-17M | $-15M | $-7M | |
| EPS (Basic) | $0.06 | $0.14 | $-1.41 | $0.04 | $-2.87 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $0.02 | $0.05 | $-1.41 | $0.03 | $-2.87 | · | · | · | · | · | · | · | |
| Shares (Basic) | 89,344,622 | 85,094,948 | 65,831,675 | 63,588,119 | 30,640,977 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 103,180,037 | 102,293,526 | 65,831,675 | 75,686,406 | 30,640,977 | · | · | · | · | · | · | · | |
| EBITDA | $14M | $18M | $-66M | $-8M | · | $-57M | $-57M | · | $-22M | $-20M | $-13M | $-29M |
Bilanço 27
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $49M | $12M | $34M | $25M | $44M | $30M | $15M | $31M | $14M | $10M | $29M | $2M | |
| Short-term Investments | $15M | $15M | · | · | $3M | $49M | $61M | $89M | $18M | $7M | $3M | $51M | |
| Receivables | $31M | $20M | $15M | · | $2M | $3M | $15M | · | · | · | · | $141.0K | |
| Inventory | $10M | $6M | $4M | $6M | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $10M | $3M | · | $2M | $3M | $7M | $4M | $4M | $1M | $958.0K | $2M | $103.0K | |
| Other Current Assets | $1M | $1M | $1M | $843.0K | · | · | · | · | · | · | · | · | |
| Current Assets | $149M | $65M | $57M | $50M | $51M | $90M | $96M | $124M | $39M | $38M | $69M | $2M | |
| PP&E (Net) | $28M | $24M | $23M | $18M | $970.0K | $433.0K | $304.0K | $386.0K | $276.0K | $444.0K | $698.0K | $911.0K | |
| PP&E (Gross) | $39M | $29M | $28M | $22M | · | · | · | $671.0K | $2M | $2M | $6M | $8M | |
| Accum. Depreciation | $11M | $6M | $4M | $4M | · | · | $400.0K | $300.0K | $2M | $2M | $6M | $7M | |
| Intangibles | $5M | $273.0K | $273.0K | $297.0K | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $8M | $3M | $995.0K | $3M | $472.0K | $528.0K | $257.0K | $543.0K | $128.0K | · | · | $12.0K | |
| Total Assets | $220M | $125M | $117M | $85M | $56M | $95M | $99M | $125M | $40M | $38M | $70M | $3M | |
| Accounts Payable | $1M | $108.0K | $355.0K | $122.0K | $6M | $6M | $4M | $1M | $747.0K | $837.0K | $939.0K | $249.0K | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| Current Liabilities | $24M | $20M | $20M | $12M | $14M | $18M | $29M | $5M | $9M | $22M | $38M | $2M | |
| Capital Leases | $2M | $885.0K | $199.0K | $121.0K | $408.0K | $981.0K | $1M | · | · | · | · | · | |
| Other Non-current Liabilities | $2M | $7.0K | $49.0K | $55.0K | · | · | · | · | · | · | · | · | |
| Total Liabilities | $31M | $27M | $38M | $13M | $15M | $19M | $30M | $5M | $9M | $22M | $38M | $3M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Common Stock | $91.0K | $86.0K | $77.0K | $64.0K | $31.0K | $22.0K | $12.0K | $12.0K | $6.0K | $1.0K | $1.0K | $34.0K | |
| Paid-in Capital | $173M | $136M | $68M | $33M | $444M | $391M | $327M | $323M | $204M | $164M | $162M | $7M | |
| Retained Earnings | $-113M | $-73M | $-86M | $7M | $-403M | $-315M | $-259M | $-203M | $-173M | $-148M | $-131M | $-116M | |
| AOCI | $-908.0K | $-3M | $-2M | $-392.0K | · | $5.0K | $34.0K | $-4.0K | · | $-1.0K | $1.0K | $4.0K | |
| Stockholders' Equity | $62M | $63M | $-16M | $43M | $41M | $76M | $68M | $120M | $31M | $16M | $31M | $-109M | |
| Liabilities + Equity | $220M | $125M | $117M | $85M | $56M | $95M | $99M | $125M | $40M | $38M | $70M | $3M | |
| Shares Outstanding | 91,314,007 | 86,307,544 | 76,595,616 | 63,588,119 | 31,409,707 | 22,097,820 | 12,040,835 | 11,954,528 | 6,081,230 | 801,756 | 762,005 | 370,944 |
Nakit Akışı 19
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $1M | $1M | $290.0K | $138.0K | $146.0K | $149.0K | $173.0K | $389.0K | $470.0K | $680.0K | |
| Stock-based Comp | $7M | $831.0K | $7M | $13M | $3M | $4M | $3M | $3M | $863.0K | $635.0K | $326.0K | $244.0K | |
| Deferred Tax | $-1M | $-1M | $-834.0K | $-890.0K | · | · | · | · | · | · | · | $72.0K | |
| Amort. of Intangibles | $576.0K | $38.0K | $100.0K | $200.0K | · | · | · | · | · | · | · | · | |
| Restructuring | · | · | · | $1M | $4M | · | · | · | $0 | · | · | · | |
| Other Non-cash | $-17M | $-23M | $104M | $-26M | · | $-3M | $8M | · | $585.0K | $-3M | $-5M | $-6M | |
| Operating Cash Flow | $1M | $-4M | $26M | $11M | $-84M | $-55M | $-44M | $-29M | $-20M | $-18M | $-19M | $-6M | |
| CapEx | $1M | $2M | $9M | $5M | $839.0K | · | $64.0K | $376.0K | $23.0K | $468.0K | $272.0K | $4.0K | |
| Investing Cash Flow | $-474.0K | $-20M | $-20M | $-14M | $48M | $10M | $27M | $-71M | $-11M | · | · | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $-1M | |
| Stock Issued | · | $773.0K | · | · | · | · | · | · | $5M | $958.0K | · | $296.0K | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | $82.0K | · | |
| Net Stock Activity | · | $773.0K | · | · | · | · | · | · | $5M | $958.0K | $-82.0K | $296.0K | |
| Dividends Paid | · | · | · | $45M | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $24M | $2M | $2M | $-45M | $50M | $60M | $327.0K | $111M | $21M | · | · | · | |
| Net Change in Cash | $25M | $-22M | $8M | $-5M | $14M | $15M | $-16M | $11M | $-10M | $-19M | $28M | $-1M | |
| Taxes Paid | $6M | $9M | $6M | $6M | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-180.0K | $-6M | $17M | · | · | · | $-44M | · | $-20M | $-19M | $-19M | $-34M | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | $-35M |
Kârlılık 8
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 96.3% | 95.9% | · | · | · | · | · | · | · | · | · | |
| Operating Margin | 9.8% | 15.3% | -59.3% | · | · | -273.9% | · | · | · | · | · | -10805.1% | |
| Net Margin | 8.5% | 16.9% | -75.3% | · | · | -268.5% | · | · | · | · | · | -11862.9% | |
| Pretax Margin | 12.4% | 21.9% | -67.8% | · | · | · | · | · | · | · | · | -10596.0% | |
| EBITDA Margin | 12.0% | 16.8% | -58.3% | · | · | -273.2% | · | · | · | · | · | -10677.5% | |
| ROA | 6.8% | 14.8% | -84.9% | -19.6% | · | -58.2% | -49.4% | · | -55.6% | -31.5% | -40.7% | -25.3% | |
| ROE | 11.7% | 75.4% | 387.3% | -214.5% | · | -66.1% | -73.8% | · | -92.0% | -71.4% | 37.9% | -1073.6% | |
| ROIC | 7.4% | 19.7% | 471.8% | 41.4% | · | · | · | · | · | · | · | -30.5% |
Likidite ve Solventlik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.6 | 3.3 | 2.9 | 1.7 | · | 5.0 | 3.3 | · | 4.5 | 1.7 | 1.8 | 37.1 | |
| Quick Ratio | 4.6 | 2.4 | 1.7 | 1.3 | · | 4.6 | 3.2 | · | 3.7 | 0.8 | 0.9 | 36.9 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | -9.3 | -1291.9 |
Verimlilik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.9 | 1.1 | · | · | 0.2 | · | · | · | · | · | 0.0 | |
| Inventory Turnover | · | 0.7 | 0.9 | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 4.6 | 6.1 | · | · | · | 2.3 | · | · | · | · | · | 1.3 |
Büyüme Oranları 7
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.2% | -6.8% | 10.9% | 1294.0% | -65.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 4.5% | 143.4% | 75.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 41.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -60.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -12.6% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -44.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 31.8% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 13
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $117M | $106M | $113M | $102M | $7M | $21M | · | $6.0K | $1M | $248.0K | $248.0K | $275.0K | |
| Net Income TTM | $10M | $18M | $-85M | $4M | $-88M | $-56M | $-55M | $-30M | $-22M | $-17M | $-15M | $-7M | |
| Market Cap | $645M | $1.04B | $1.97B | $300M | · | $2.09B | $1.23B | · | $1.24B | $117M | $8.05B | $139.98B | |
| P/E | 353.0 | 242.0 | -18.2 | 265.0 | -4.8 | -64.8 | -70.0 | -81.1 | -140.1 | -100.2 | -482.4 | -2837.2 | |
| P/S | 5.5 | 9.9 | 17.3 | 2.9 | · | 99.8 | · | · | 1222.2 | 472.8 | 32458.2 | 509025.8 | |
| P/B | 6.1 | 16.5 | -124.3 | -13.8 | · | 27.5 | 18.0 | · | 40.4 | 7.3 | 256.2 | 1283.2 | |
| P / Tangible Book | 6.4 | 16.6 | · | 7.1 | 10.4 | 27.5 | · | · | · | · | · | · | |
| P / Cash Flow | 638.3 | -286.8 | 76.0 | -9.1 | · | -38.0 | -28.2 | · | -62.4 | -6.3 | -421.1 | -4059.5 | |
| P / FCF | -3581.5 | -175.3 | 113.3 | · | · | · | -28.2 | · | -62.3 | -6.2 | -415.1 | -4059.0 | |
| Dividend Yield | · | · | · | 15.0% | · | · | · | · | · | · | · | · | |
| Earnings Yield | 0.28% | 0.41% | -5.5% | 0.38% | -21.0% | -1.5% | -1.4% | -1.2% | -0.71% | -1.0% | -0.21% | -0.04% | |
| Payout Ratio | · | · | · | -546.4% | · | · | · | · | · | · | · | · | |
| Annual Payout | · | · | · | $45M | · | · | · | · | · | · | · | · |
Gelir Tablosu 16
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $29M | $23M | $37M | $31M | $30M | $22M | $28M | $25M | $25M | $27M | $27M | $32M | $29M | $25M | · | · | |
| Cost of Revenue | $2M | $1M | $2M | $2M | $1M | $894.0K | $1M | $958.0K | $770.0K | $979.0K | $1M | $1M | $1M | $1M | · | · | |
| Gross Profit | · | · | · | $29M | $26M | $21M | · | $25M | $24M | $26M | $26M | $31M | $28M | $24M | · | · | |
| R&D Expense | · | $7M | $5M | $2M | $8M | $3M | $4M | $3M | $3M | $2M | $5M | $3M | $4M | $3M | · | $803.0K | |
| SG&A Expense | $8M | $7M | $7M | $4M | $7M | $5M | $5M | $4M | $3M | $3M | $10M | $1M | $2M | $2M | $4M | $4M | |
| Operating Expenses | $43M | $32M | $41M | $22M | $32M | $20M | $30M | $20M | $21M | $18M | $118M | $18M | $23M | $17M | $119M | $5M | |
| Operating Income | $-14M | $-9M | $118.0K | $7M | $-2M | $2M | $665.0K | $4M | $3M | $8M | $-92M | $13M | $5M | $7M | $-22M | $-5M | |
| Other Non-op | $-943.0K | $29.0K | $-2M | $727.0K | $-488.0K | $107.0K | $-2M | $-75.0K | $-72.0K | $122.0K | $-237.0K | $-1M | $629.0K | · | · | $-1.0K | |
| Pretax Income | $-14M | $-9M | $-66.0K | $8M | $-2M | $5M | $772.0K | $4M | $6M | $12M | $-100M | $11M | $6M | $6M | $-23M | $-5M | |
| Income Tax | $-164.0K | $621.0K | $1M | $2M | $662.0K | $901.0K | $203.0K | $1M | $1M | $3M | $699.0K | $4M | $2M | $2M | $5M | $0 | |
| Net Income | $-14M | $-19M | $-1M | $6M | $-2M | $5M | $569.0K | $3M | $5M | $10M | $-101M | $8M | $4M | $4M | $-28M | $-5M | |
| EPS (Basic) | $-0.12 | $-0.10 | $-0.01 | $0.04 | $-0.02 | $0.03 | $0.00 | $0.01 | $0.04 | $0.09 | $-1.54 | $0.06 | $0.03 | $0.04 | $-0.98 | $-0.16 | |
| EPS (Diluted) | $-0.12 | $-0.10 | $-0.01 | $0.03 | $-0.03 | $0.00 | $0.00 | $0.01 | $0.01 | $0.03 | $-1.51 | $0.05 | $0.02 | $0.03 | $-0.99 | $-0.16 | |
| Shares (Basic) | 100,637,599 | 91,317,142 | -177,045,292 | 90,850,040 | 89,119,344 | 86,420,530 | -169,316,980 | 85,643,646 | 85,502,403 | 83,265,879 | -124,932,682 | 63,588,119 | 63,588,119 | 63,588,119 | -30,829,566 | 31,484,542 | |
| Shares (Diluted) | 100,637,599 | 91,344,584 | -205,463,888 | 103,971,546 | 89,203,138 | 101,970,672 | -205,146,932 | 102,640,373 | 102,205,888 | 102,594,197 | -170,898,339 | 78,904,324 | 78,904,324 | 78,921,366 | -18,737,151 | 31,484,542 | |
| EBITDA | · | $-9M | · | $7M | $2M | $3M | · | $4M | $3M | $8M | · | $-2M | $-3M | $181.0K | · | $-5M |
Bilanço 25
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43M | $38M | $37M | $40M | $36M | $15M | $12M | $16M | $16M | $30M | $34M | $2M | $7M | $8M | $25M | $23M | |
| Short-term Investments | $14M | $12M | $15M | $20M | $18M | $15M | $15M | $9M | $9M | $8M | · | · | · | · | · | · | |
| Receivables | $28M | $23M | $31M | $26M | $25M | $20M | $20M | · | · | · | $15M | · | · | · | · | · | |
| Inventory | $11M | $11M | · | · | $9M | $8M | · | $6M | $6M | $5M | $4M | · | · | · | $6M | · | |
| Prepaid Expense | $8M | $4M | · | $3M | $3M | $8M | · | · | · | · | · | · | $697.0K | $915.0K | · | $2M | |
| Other Current Assets | · | · | $1M | · | · | · | $1M | $2M | $2M | $2M | $1M | · | · | · | $843.0K | · | |
| Current Assets | $122M | $92M | $102M | $99M | $91M | $68M | $65M | $55M | $54M | $63M | $57M | $5M | $8M | $14M | $50M | $30M | |
| PP&E (Net) | $27M | $24M | $24M | $24M | $23M | $24M | $24M | $24M | $24M | $24M | $23M | · | · | $1.0K | $18M | $124.0K | |
| PP&E (Gross) | $40M | $32M | $31M | $31M | $30M | $30M | $29M | $30M | $28M | $28M | $28M | · | · | · | $22M | · | |
| Accum. Depreciation | $13M | $8M | $8M | $7M | $6M | $6M | $6M | $5M | $5M | $5M | $4M | · | · | · | $4M | · | |
| Intangibles | $5M | $5M | $5M | $5M | $5M | $5M | $273.0K | $184.0K | $186.0K | $196.0K | $205.0K | · | · | · | $297.0K | · | |
| Other Non-current Assets | $7M | $5M | $2M | $5M | $5M | $6M | $3M | $3M | $1M | $802.0K | $995.0K | $168.0K | $168.0K | $168.0K | $3M | $168.0K | |
| Total Assets | $199M | $162M | $166M | $159M | $153M | $130M | $125M | $125M | $121M | $122M | $117M | $10M | $12M | $19M | $85M | $31M | |
| Accounts Payable | $1M | $265.0K | $124.0K | $556.0K | $71.0K | $122.0K | $108.0K | $303.0K | $271.0K | $330.0K | $355.0K | $158.0K | $5.0K | $16.0K | $122.0K | $41.0K | |
| Current Liabilities | $29M | $20M | $18M | $16M | $17M | $19M | $20M | $15M | $16M | $19M | $20M | $2M | $3M | $7M | $12M | $2M | |
| Capital Leases | $2M | $72.0K | $303.0K | $539.0K | $771.0K | $780.0K | $885.0K | $1M | $1M | $175.0K | $199.0K | · | · | · | $121.0K | · | |
| Other Non-current Liabilities | $70.0K | $1M | $1M | $1M | $1M | $1M | $7.0K | $2.0K | $47.0K | $48.0K | $49.0K | · | · | · | $55.0K | · | |
| Total Liabilities | $34M | $25M | $24M | $22M | $23M | $25M | $27M | $27M | $28M | $33M | $38M | $6M | $7M | $11M | $13M | $2M | |
| Common Stock | $106.0K | $91.0K | $91.0K | $91.0K | $91.0K | $87.0K | $86.0K | $85.0K | $85.0K | $85.0K | $77.0K | $37.0K | $37.0K | $37.0K | $64.0K | $31.0K | |
| Paid-in Capital | $241M | $175M | $172M | $167M | $161M | $138M | $136M | $134M | $134M | $133M | $68M | $385M | $385M | $385M | $33M | $400M | |
| Retained Earnings | $-138M | $-78M | $-68M | $-67M | $-70M | $-71M | $-73M | $-73M | $-74M | $-78M | $-86M | $-415M | $-413M | $-411M | $7M | $-370M | |
| AOCI | $1M | $586.0K | $-779.0K | $-2M | $-2M | $-2M | $-3M | $-946.0K | $-2M | $-2M | $-2M | · | · | · | $-392.0K | · | |
| Stockholders' Equity | $108M | $101M | $106M | $102M | $92M | $68M | $63M | $63M | $60M | $57M | $-16M | $4M | $-28M | $-26M | $43M | $29M | |
| Liabilities + Equity | $199M | $162M | $166M | $159M | $153M | $130M | $125M | $125M | $121M | $122M | $117M | $10M | $12M | $19M | $85M | $31M | |
| Shares Outstanding | 106,033,763 | 91,337,121 | 91,314,007 | 90,890,381 | 90,822,828 | 87,636,209 | 86,307,544 | 85,769,526 | 85,537,774 | 85,423,246 | 76,595,616 | 37,978,142 | 37,974,892 | 37,759,825 | 63,588,119 | 31,490,053 |
Nakit Akışı 14
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $672.0K | $656.0K | $649.0K | $641.0K | $535.0K | $461.0K | $445.0K | $228.0K | $415.0K | $298.0K | $772.0K | $581.0K | $276.0K | $867.0K | $40.0K | |
| Stock-based Comp | $2M | $3M | $5M | $1M | $906.0K | $507.0K | $567.0K | $237.0K | $16.0K | $11.0K | $7M | $98.0K | $89.0K | $210.0K | $12M | $224.0K | |
| Amort. of Intangibles | $179.0K | $175.0K | $172.0K | $170.0K | $167.0K | $67.0K | $-80.5K | $10.0K | $8.5K | $100.0K | $-7.0K | $14.0K | $48.0K | $45.0K | · | · | |
| Other Non-cash | · | $10M | · | · | · | $-5M | · | · | · | $-7M | · | · | · | $-7M | · | · | |
| Operating Cash Flow | $-17M | $3M | $-6M | $5M | $2M | $-129.0K | $-3M | $2M | $-5M | $3M | $3M | $31M | $21M | $10M | $42M | $-7M | |
| CapEx | $262.0K | $178.0K | $144.0K | $668.0K | $256.0K | $122.0K | $-65.0K | $693.0K | $1M | $231.0K | $2M | $2M | $2M | $2M | · | · | |
| Investing Cash Flow | $10M | $-3M | $2M | $-1M | $-3M | $2M | $-2M | $-2M | $-8M | $-7M | $1M | $-26M | $-16M | $-8M | $-69M | $0 | |
| Stock Issued | · | · | · | · | $22M | $509.0K | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $509.0K | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid | · | · | · | · | · | · | · | · | · | · | · | $2M | $4M | $8M | · | · | |
| Financing Cash Flow | $-8.0K | $21.0K | $318.0K | $365.0K | $22M | $1M | $964.0K | $324.0K | $156.0K | $658.0K | $15M | $-1M | $-4M | $-8M | · | $-45M | |
| Net Change in Cash | $-6M | $431.0K | $-3M | $4M | $21M | $3M | $-4M | $-231.0K | $-14M | $-4M | $7M | $16M | $12M | $3M | $16M | $-52M | |
| Taxes Paid | · | $1M | $1M | $687.0K | $447.0K | $3M | $761.0K | $537.0K | $6M | $1M | $961.0K | $1M | $4M | $463.0K | · | · | |
| Free Cash Flow | · | $3M | · | · | · | $-251.0K | · | · | · | $3M | · | · | · | · | · | · |
Kârlılık 8
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | 94.7% | 95.7% | 96.0% | · | 96.2% | 97.0% | 96.4% | · | · | · | · | · | · | |
| Operating Margin | · | -41.5% | · | 22.7% | 8.1% | 10.3% | · | 16.6% | 12.9% | 29.7% | · | · | · | · | · | · | |
| Net Margin | · | -43.8% | · | 19.4% | 5.9% | 16.9% | · | 11.2% | 18.0% | 36.6% | · | · | · | · | · | · | |
| Pretax Margin | · | -41.0% | · | 25.0% | 8.4% | 21.0% | · | 15.4% | 23.9% | 45.9% | · | · | · | · | · | · | |
| EBITDA Margin | · | -38.6% | · | 22.7% | 8.1% | 12.7% | · | 16.6% | 12.9% | 31.2% | · | · | · | · | · | · | |
| ROA | · | -6.8% | · | 4.2% | 1.1% | 3.0% | · | 4.2% | 6.8% | 14.1% | · | -7.7% | -5.2% | 0.88% | · | -8.9% | |
| ROE | · | -11.6% | · | 7.2% | 2.1% | 6.0% | · | 8.6% | 28.3% | 64.8% | · | -9.6% | -9.7% | 46.0% | · | -10.8% | |
| ROIC | · | -9.8% | · | 5.3% | 1.7% | 2.7% | · | 4.9% | 4.1% | 11.3% | · | -46.2% | 9.0% | -0.65% | · | · |
Likidite ve Solventlik 2
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 4.6 | · | 6.2 | 5.4 | 3.6 | · | 3.7 | 3.4 | 3.2 | · | 2.9 | 2.7 | 2.0 | · | 18.4 | |
| Quick Ratio | · | 3.7 | · | 5.4 | 4.7 | 2.6 | · | 1.7 | 1.6 | 1.9 | · | 1.2 | 2.5 | 1.2 | · | 14.0 |
Verimlilik 3
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.4 | 0.4 | 0.4 | · | · | · | · | · | · | |
| Inventory Turnover | · | 0.1 | · | · | 0.2 | 0.1 | · | 0.3 | 0.3 | 0.4 | · | · | · | · | · | · | |
| Receivables Turnover | · | 1.0 | · | 2.3 | 2.0 | 2.1 | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 11
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $112M | $102M | · | $105M | $100M | $100M | · | $110M | $114M | $113M | · | · | · | · | · | $6M | |
| Net Income TTM | $-29M | $1M | · | $14M | $13M | $21M | · | $25M | $26M | $25M | · | $11M | $55M | $36M | · | $7M | |
| Market Cap | · | $637M | · | $678M | $668M | $677M | · | $1.08B | $1.02B | $1.49B | · | $273M | $199M | $119M | · | $236M | |
| P/E | -30.0 | -99.6 | · | 186.5 | 367.5 | 154.4 | · | 125.4 | 108.5 | 134.5 | · | -120.0 | 3.4 | 3.0 | · | 34.1 | |
| P/S | · | 6.2 | · | 6.5 | 6.7 | 6.8 | · | 9.8 | 9.0 | 13.2 | · | · | · | · | · | 41.5 | |
| P/B | · | 6.3 | · | 6.7 | 7.3 | 9.9 | · | 17.0 | 16.9 | 26.4 | · | 77.7 | -7.0 | -4.6 | · | 8.0 | |
| P / Tangible Book | 6.8 | 6.6 | · | 7.0 | 7.7 | 10.7 | · | 17.1 | 17.0 | 26.5 | · | 77.7 | · | · | · | 8.0 | |
| P / Cash Flow | · | 200.2 | · | · | · | -5244.6 | · | · | · | 517.8 | · | · | · | -19.1 | · | · | |
| P / FCF | · | 212.1 | · | · | · | -2695.4 | · | · | · | 562.8 | · | · | · | · | · | · | |
| Earnings Yield | -3.3% | -1.0% | · | 0.54% | 0.27% | 0.65% | · | 0.80% | 0.92% | 0.74% | · | -0.83% | 29.1% | 33.3% | · | 2.9% | |
| Payout Ratio | · | · | · | · | · | · | · | · | · | · | · | · | · | 2986.2% | · | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $117M | $106M | $113M | $102M | $7M |
| Brüt Kâr Marjı % | — | 96.3% | 95.9% | — | — |
| Faaliyet Kâr Marjı % | 9.8% | 15.3% | -59.3% | — | — |
| Net Gelir | $10M | $18M | $-85M | $4M | $-88M |
| Seyreltilmiş Hisse Başı Kâr | $0.02 | $0.05 | $-1.41 | $0.03 | $-2.87 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Cari Oran | 5.6 | 3.3 | 2.9 | 1.7 | — |
| Cari Oran | 4.6 | 2.4 | 1.7 | 1.3 | — |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-180.0K | $-6M | $17M | — | — |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 63 dosya · $55.4M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 17 (+2 önceki Ç'ye göre) | 7 (+4 önceki Ç'ye göre) | 26 (+8 önceki Ç'ye göre) | 8 (0 önceki Ç'ye göre) | +4.9M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| HSG Holding Ltd | $24.714.470 | 3.750.299 | 44,65% | Hisse senetleri |
| VANGUARD GROUP INC | $7.437.901 | 1.053.527 | 13,44% | Hisse senetleri |
| Octagon Capital Advisors LP | $6.289.601 | 954.416 | 11,36% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $5.778.949 | 876.927 | 10,44% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $3.006.906 | 456.126 | 5,43% | Hisse senetleri |
| STATE STREET CORP | $1.617.199 | 245.402 | 2,92% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.214.445 | 184.286 | 2,19% | Hisse senetleri |
| SBI Securities Co., Ltd. | $1.098.883 | 166.750 | 1,99% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $995.571 | 151.073 | 1,80% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $816.850 | 123.953 | 1,48% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $568.289 | 86.235 | 1,03% | Hisse senetleri |
| Bank of New York Mellon Corp | $227.935 | 34.588 | 0,41% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $171.392 | 24.590 | 0,31% | Hisse senetleri |
| STRS OHIO | $170.022 | 25.800 | 0,31% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $161.521 | 24.510 | 0,29% | Hisse senetleri |
| Nuveen, LLC | $161.488 | 24.505 | 0,29% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $121.836 | 18.488 | 0,22% | Hisse senetleri |
| RHUMBLINE ADVISERS | $111.131 | 16.865 | 0,20% | Hisse senetleri |
| FMR LLC | $98.679 | 14.974 | 0,18% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $82.539 | 12.525 | 0,15% | Hisse senetleri |
| Polymer Capital Management (US) LLC | $77.630 | 11.780 | 0,14% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $65.788 | 9.983 | 0,12% | Hisse senetleri |
| Police & Firemen's Retirement System of New Jersey | $59.382 | 9.011 | 0,11% | Hisse senetleri |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $55.659 | 8.446 | 0,10% | Hisse senetleri |
| CITIGROUP INC | $49.603 | 7.527 | 0,09% | Hisse senetleri |
| BlackRock, Inc. | $28.752 | 4.363 | 0,05% | Hisse senetleri |
| Russell Investments Group, Ltd. | $23.803 | 3.612 | 0,04% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $22.973 | 3.486 | 0,04% | Hisse senetleri |
| NORTHERN TRUST CORP | $18.887 | 2.866 | 0,03% | Hisse senetleri |
| BARCLAYS PLC | $18.558 | 2.816 | 0,03% | Hisse senetleri |
| NEW YORK STATE COMMON RETIREMENT FUND | $17.793 | 2.700 | 0,03% | Hisse senetleri |
| Tower Research Capital LLC (TRC) | $16.271 | 2.469 | 0,03% | Hisse senetleri |
| MORGAN STANLEY | $16.106 | 2.444 | 0,03% | Hisse senetleri |
| Legal & General Group Plc | $13.536 | 2.054 | 0,02% | Hisse senetleri |
| Ameritas Investment Partners, Inc. | $4.501 | 683 | 0,01% | Hisse senetleri |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $4.454 | 639 | 0,01% | Hisse senetleri |
| ROYAL BANK OF CANADA | $4.000 | 537 | 0,01% | Hisse senetleri |
| Activest Wealth Management | $3.512 | 533 | 0,01% | Hisse senetleri |
| Arax Advisory Partners | $1.621 | 246 | 0,00% | Hisse senetleri |
| MERCER GLOBAL ADVISORS INC /ADV | $1.285 | 195 | 0,00% | Hisse senetleri |
| Sterling Capital Management LLC | $1.061 | 161 | 0,00% | Hisse senetleri |
| GAMMA Investing LLC | $962 | 146 | 0,00% | Hisse senetleri |
| CWM, LLC | $725 | 104 | 0,00% | Hisse senetleri |
| Physician Wealth Advisors, Inc. | $541 | 82 | 0,00% | Hisse senetleri |
| Bare Financial Services, Inc | $521 | 79 | 0,00% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $435 | 66 | 0,00% | Hisse senetleri |
| JPMORGAN CHASE & CO | $361 | 56 | 0,00% | Hisse senetleri |
| GoalVest Advisory LLC | $330 | 50 | 0,00% | Hisse senetleri |
| Allworth Financial LP | $251 | 38 | 0,00% | Hisse senetleri |
| DEUTSCHE BANK AG\ | $244 | 37 | 0,00% | Hisse senetleri |
| OSAIC HOLDINGS, INC. | $216 | 33 | 0,00% | Hisse senetleri |
| UBS Group AG | $165 | 25 | 0,00% | Hisse senetleri |
| PRICE T ROWE ASSOCIATES INC /MD/ | $100 | 15.031 | 0,00% | Hisse senetleri |
| Caitong International Asset Management Co., Ltd | $99 | 15 | 0,00% | Hisse senetleri |
| Integrated Wealth Concepts LLC | $94 | 14 | 0,00% | Hisse senetleri |
| EverSource Wealth Advisors, LLC | $53 | 8 | 0,00% | Hisse senetleri |
| Farther Finance Advisors, LLC | $53 | 8 | 0,00% | Hisse senetleri |
| Optiver Holding B.V. | $40 | 6 | 0,00% | Hisse senetleri |
| Smartleaf Asset Management LLC | $39 | 6 | 0,00% | Hisse senetleri |
| State of Alaska, Department of Revenue | $34 | 5.219 | 0,00% | Hisse senetleri |
| ROTHSCHILD INVESTMENT LLC | $7 | 1 | 0,00% | Hisse senetleri |
| Essential Partners LLC | $7 | 1 | 0,00% | Hisse senetleri |
| Covestor Ltd | $0 | 48 | 0,00% | Hisse senetleri |
Şirket yöneticileri 66 içeriden öğrenenler · 26 yöneticiler · 32 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Ying Luo | Chief Executive Officer | 08 Haziran 2026 A | 2.565.226 | 0 | 2 | $-82.927 |
| Han Ying | Chief Executive Officer | 14 Ağustos 2024 A | — | 0 | 0 | $0 |
| Charles C Wu | Chief Executive Officer | 20 Kasım 2023 A | — | 0 | 0 | $0 |
| Donald J Debethizy | President and CEO | 04 Mayıs 2012 A | 798 | 0 | 0 | $0 |
| Thomas Wilson Eastling | Chief Financial Officer | 04 Mayıs 2026 A | 15.000 | 0 | 0 | $0 |
| Ruoyu Chen | Chief Financial Officer | 07 Ocak 2026 A | — | 0 | 0 | $0 |
| Seline E. Miller | SVP Finance; Interim CFO & PAO | 31 Ağustos 2023 D | 0 | 0 | 0 | $0 |
| Clinton Musil | Chief Financial Officer | 08 Şubat 2021 A | — | 0 | 0 | $0 |
| Fletcher Payne | Chief Financial Officer | 12 Ağustos 2019 A | 3.744 | 0 | 0 | $0 |
| Mauri K Hodges | Treasurer, CFO | 14 Ağustos 2015 A | 1.159 | 0 | 0 | $0 |
| Alan A Musso | SVP, Fin+Admin, CFO & Treas | 17 Ekim 2014 A | 57.799 | 0 | 0 | $0 |
| Songjiang Ma | President | 28 Mayıs 2025 S | 2.806.084 | 0 | 0 | $0 |
| Weiguo Ye | Chief Operating Officer | 18 Haziran 2026 M | 700.000 | 0 | 16 | $-869.947 |
| Joshua Benjamin Bergmann | GC and Corporate Secretary | 08 Haziran 2026 A | — | 0 | 0 | $0 |
| Grant E. Blouse | Chief Scientific Officer | 09 Ağustos 2022 P | 9.417 | 0 | 0 | $0 |
| Howard Levy | Chief Medical Officer | 09 Ağustos 2021 P | 639 | 0 | 0 | $0 |
| Veronica Cai | Controller | 13 Mart 2020 P | 7.353 | 0 | 0 | $0 |
| Edwin Madison | Chief Scientific Officer | 22 Ekim 2015 A | 31.008 | 0 | 0 | $0 |
| Patrick C. Rock | Secretary, GC | 14 Ağustos 2015 A | 45.000 | 0 | 0 | $0 |
| Steven M. Toler | VP, Clin Pharm Sciences | 17 Ekim 2014 A | 46.000 | 0 | 0 | $0 |
| David A. Hosford | VP, Clin Dev & Reg Affairs | 23 Ocak 2014 A | — | 0 | 0 | $0 |
| Karen A Hicks | VP, Human Resources | 17 Ocak 2013 A | 0 | 0 | 0 | $0 |
| Peter A Zorn | SVP, Lgl Affrs, GC & Secretary | 17 Ocak 2013 A | 0 | 0 | 0 | $0 |
| Merouane Bencherif | SVP and Senior Scien Fellow | 17 Ocak 2013 A | 15.938 | 0 | 0 | $0 |
| William S Caldwell | SVP - Drug Discovery and Dev. | 20 Eylül 2011 G | 500 | 0 | 0 | $0 |
| Geoffrey C Dunbar | SVP, Clin. Dev. & Reg. Affairs | 29 Mart 2011 A | 1.153 | 0 | 0 | $0 |
| Claire Weston | Yönetim kurulu üyesi | 03 Ağustos 2026 A | — | 0 | 0 | $0 |
| Maxwell Kirkby | Yönetim kurulu üyesi | 03 Ağustos 2026 A | — | 0 | 0 | $0 |
| Dan Weng | Yönetim kurulu üyesi | 10 Haziran 2026 A | — | 0 | 0 | $0 |
| Ping Zhang | Yönetim kurulu üyesi | 10 Haziran 2026 A | — | 0 | 0 | $0 |
| Rodney L Nussbaum | Yönetim kurulu üyesi | 10 Haziran 2026 A | — | 0 | 0 | $0 |
| Renate Parry | Yönetim kurulu üyesi | 10 Haziran 2026 A | — | 0 | 0 | $0 |
| Gordon Carmichael | Yönetim kurulu üyesi | 10 Haziran 2026 A | — | 0 | 0 | $0 |
| David M. Epstein | Yönetim kurulu üyesi | 10 Haziran 2026 A | — | 0 | 0 | $0 |
| Nassim Usman | Yönetim kurulu üyesi | 28 Haziran 2024 M | 1.636 | 0 | 0 | $0 |
| Andrea Hunt | Yönetim kurulu üyesi | 31 Ağustos 2023 D | 0 | 0 | 0 | $0 |
| Augustine Lawlor | Yönetim kurulu üyesi | 31 Ağustos 2023 D | 0 | 0 | 0 | $0 |
| Geoffrey Ling M.D. | Yönetim kurulu üyesi | 07 Ocak 2022 A | 31.790 | 0 | 0 | $0 |
| Eddie Williams | Yönetim kurulu üyesi | 07 Ocak 2022 A | 34.804 | 0 | 0 | $0 |
| Errol B Desouza | Yönetim kurulu üyesi | 01 Ekim 2021 A | 29.801 | 0 | 0 | $0 |
| Jeanne Y Jew | Yönetim kurulu üyesi | 09 Eylül 2021 A | — | 0 | 0 | $0 |
| Sharon Tetlow | Yönetim kurulu üyesi | 09 Haziran 2021 A | 3.635 | 0 | 0 | $0 |
| John P Richard | Yönetim kurulu üyesi | 13 Mart 2020 P | 3.716 | 0 | 0 | $0 |
| Stephen A Hill | Yönetim kurulu üyesi | 06 Eylül 2018 D | 1.190 | 0 | 0 | $0 |
| Harold E Selick | Yönetim kurulu üyesi | 16 Ocak 2018 A | 16.614 | 0 | 0 | $0 |
| Jeff Himawan | Yönetim kurulu üyesi | 20 Ağustos 2015 J | 1.179.352 | 0 | 0 | $0 |
| Alan W Dunton | Yönetim kurulu üyesi | 14 Ağustos 2015 A | 10.000 | 0 | 0 | $0 |
| Charles A Blixt | Yönetim kurulu üyesi | 14 Ağustos 2015 A | 10.000 | 0 | 0 | $0 |
| Julia R Brown | Yönetim kurulu üyesi | 14 Ağustos 2015 A | 10.000 | 0 | 0 | $0 |
| SKALETSKY MARK B | Yönetim kurulu üyesi | 07 Haziran 2013 A | 11.332 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 21 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Songjiang Ma, Yueying Zhu | 07 Mayıs 2026 | 6,33% | Değişiklik | M&A / satış | SEC |
| Ying Luo, Ping Lan | 06 Mayıs 2026 | 8,60% | Değişiklik | M&A / satış | SEC |
| GNI USA, Inc., GNI Group Ltd. ×4 başvurular | 06 Mayıs 2026 | 69,10% | Değişiklik | M&A / satış | SEC |
| Ying Luo (“Mr. Luo”), Ping Lan | 06 Eylül 2024 | — | İlk başvuru | Pasif yatırım | SEC |
| Songjiang Ma (“Mr. Ma”), Yueying Zhu | 06 Eylül 2024 | — | İlk başvuru | Pasif yatırım | SEC |
| GNI Group Ltd., GNI Hong Kong Limited, GNI USA, Inc. ×2 başvurular | 31 Ekim 2023 | — | İlk başvuru | — | SEC |
| JDS1, LLC, CCUR Holdings, Inc., CIDM II, LLC, Julian D. Singer, David S. Oros ×13 başvurular | 07 Ekim 2022 | — | İlk başvuru | Pasif yatırım | SEC |
| JEC II Associates, LLC, The Heidi S. Shippell-Heiland 2008 Irrevocable Trust, Michael Torok ×4 başvurular | 22 Eylül 2022 | — | İlk başvuru | — | SEC |
| Julian Singer, JDS1, LLC 2, CCUR Holdings, Inc., David S. Oros ×3 başvurular | 27 Ocak 2022 | — | İlk başvuru | — | SEC |
| 22NW Fund, LP, 22 NW, LP, 22NW Fund GP, LLC, 22NW GP, Inc., Aron R. English ×2 başvurular | 05 Ağustos 2020 | — | İlk başvuru | — | SEC |
| CCUR Holdings, Inc., Wayne Barr, Jr., JDS1, LLC, David S. Oros, Julian Singer ×3 başvurular | 17 Ocak 2020 | — | İlk başvuru | — | SEC |
| Morgenthaler Management Partners VIII, LLC (“MMP VIII”), Morgenthaler Partners VIII, L.P. (“MP VIII”), Robert C. Bellas, Jr. (“Bellas”), Ralph E. Christoffersen (“Christoffersen”), John Lutsi (“Lutsi”), Gary J. Morgenthaler (“Morgenthaler”), Robert D. Pavey (“Pavey”), Gary R. Little (“Little”) | 14 Şubat 2018 | — | İlk başvuru | — | SEC |
| HealthCare Ventures VIII, L.P., HealthCare Partners VIII, L.P., HealthCare Partners VIII, LLC, James H. Cavanaugh, Ph.D., Harold R. Werner, John W. Littlechild, Christopher Mirabelli, Ph.D., Augustine Lawlor ×2 başvurular | 09 Şubat 2018 | — | İlk başvuru | — | SEC |
| 23 Mayıs 2017 | — | İlk başvuru | — | SEC | |
| New Enterprise Associates 10, Limited Partnership, NEA Partners 10, Limited Partnership, Michael James Barrett, Peter J. Barris, Scott D. Sandell ×4 başvurular | 29 Mart 2017 | — | İlk başvuru | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 18 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| RSSL · Global X Funds | 0,00% | 5.185 NS | 30 Nisan 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,00% | 99.892 NS | 31 Mayıs 2026 | N-PORT |
| ITWO · ProShares Trust | 0,00% | 555 NS | 31 Mayıs 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 435 NS | 31 Mayıs 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 441 NS | 31 Mayıs 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 1.907 NS | 31 Mayıs 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 11 NS | 31 Mayıs 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 18.000 NS | 31 Mayıs 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 320 NS | 30 Nisan 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15 Temmuz 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 Temmuz 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Temmuz 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Temmuz 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Temmuz 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Temmuz 2026 | Günlük |
| IWN · iShares Trust | — | — | 17 Ağustos 2026 | Günlük |
| IWO · iShares Trust | — | — | 18 Ağustos 2026 | Günlük |
| IWM · iShares Trust | — | — | 18 Ağustos 2026 | Günlük |